Shanghai Henlius Biotech, Inc. Class H (HK:2696) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Shanghai Henlius Biotech, Inc. has announced two important agreements to streamline their operations. A Business Travel Management Services Agreement was made with Hainan Fosun International Business Travel to handle various travel-related services for the company. Additionally, a General Procurement Framework Agreement was entered with Fosun High Tech to cover various administrative and functional needs, both highlighting the company’s efforts to optimize its service procurement and management capabilities.
For further insights into HK:2696 stock, check out TipRanks’ Stock Analysis page.